APA (7th ed.) Citation

TK, C., J, L., S, P., RJ, M., BI, R., B, V., . . . L, A. (2021). Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: Post hoc analysis of a randomized clinical trial. ESMO open, 6(3), 100101. https://doi.org/10.1016/j.esmoop.2021.100101

Chicago Style (17th ed.) Citation

TK, Choueiri, et al. "Efficacy and Correlative Analyses of Avelumab Plus Axitinib Versus Sunitinib in Sarcomatoid Renal Cell Carcinoma: Post Hoc Analysis of a Randomized Clinical Trial." ESMO Open 6, no. 3 (2021): 100101. https://doi.org/10.1016/j.esmoop.2021.100101.

MLA (9th ed.) Citation

TK, Choueiri, et al. "Efficacy and Correlative Analyses of Avelumab Plus Axitinib Versus Sunitinib in Sarcomatoid Renal Cell Carcinoma: Post Hoc Analysis of a Randomized Clinical Trial." ESMO Open, vol. 6, no. 3, 2021, p. 100101, https://doi.org/10.1016/j.esmoop.2021.100101.